123 related articles for article (PubMed ID: 6496744)
1. Isolation of calcium oxalate crystal growth inhibitor from rat kidney and urine.
Nakagawa Y; Abram V; Coe FL
Am J Physiol; 1984 Nov; 247(5 Pt 2):F765-72. PubMed ID: 6496744
[TBL] [Abstract][Full Text] [Related]
2. Purification and characterization of the principal inhibitor of calcium oxalate monohydrate crystal growth in human urine.
Nakagawa Y; Abram V; Kézdy FJ; Kaiser ET; Coe FL
J Biol Chem; 1983 Oct; 258(20):12594-600. PubMed ID: 6630201
[TBL] [Abstract][Full Text] [Related]
3. Isolation of nephrocalcin from kidney tissue of nine vertebrate species.
Nakagawa Y; Renz CL; Ahmed M; Coe FL
Am J Physiol; 1991 Feb; 260(2 Pt 2):F243-8. PubMed ID: 1996674
[TBL] [Abstract][Full Text] [Related]
4. Isolation from human calcium oxalate renal stones of nephrocalcin, a glycoprotein inhibitor of calcium oxalate crystal growth. Evidence that nephrocalcin from patients with calcium oxalate nephrolithiasis is deficient in gamma-carboxyglutamic acid.
Nakagawa Y; Ahmed M; Hall SL; Deganello S; Coe FL
J Clin Invest; 1987 Jun; 79(6):1782-7. PubMed ID: 3584470
[TBL] [Abstract][Full Text] [Related]
5. Glycoprotein calcium oxalate crystal growth inhibitor in urine.
Worcester EM; Nakagawa Y; Coe FL
Miner Electrolyte Metab; 1987; 13(4):267-72. PubMed ID: 3306319
[TBL] [Abstract][Full Text] [Related]
6. Growth inhibitor of calcium oxalate monohydrate crystal in vitamin B6-deficient rat urine and kidney.
Tsubouchi R; Takeuchi F; Shibata Y
J Nutr Sci Vitaminol (Tokyo); 1988 Feb; 34(1):79-84. PubMed ID: 3392610
[TBL] [Abstract][Full Text] [Related]
7. A novel basic protein from human kidney which inhibits calcium oxalate crystal growth.
Selvam R; Kalaiselvi P
BJU Int; 2000 Jul; 86(1):7-13. PubMed ID: 10886075
[TBL] [Abstract][Full Text] [Related]
8. Elucidation of multiple forms of nephrocalcin by 31P-NMR spectrometer.
Nakagawa Y; Otsuki T; Coe FL
FEBS Lett; 1989 Jul; 250(2):187-90. PubMed ID: 2753126
[TBL] [Abstract][Full Text] [Related]
9. Molecular abnormality of urinary glycoprotein crystal growth inhibitor in calcium nephrolithiasis.
Nakagawa Y; Parks JH; Kézdy FJ; Coe FL
Trans Assoc Am Physicians; 1985; 98():281-9. PubMed ID: 3842199
[No Abstract] [Full Text] [Related]
10. Urine glycoprotein crystal growth inhibitors. Evidence for a molecular abnormality in calcium oxalate nephrolithiasis.
Nakagawa Y; Abram V; Parks JH; Lau HS; Kawooya JK; Coe FL
J Clin Invest; 1985 Oct; 76(4):1455-62. PubMed ID: 4056037
[TBL] [Abstract][Full Text] [Related]
11. Properties and function of nephrocalcin: mechanism of kidney stone inhibition or promotion.
Nakagawa Y
Keio J Med; 1997 Mar; 46(1):1-9. PubMed ID: 9095576
[TBL] [Abstract][Full Text] [Related]
12. Urinary crystal surface binding substances on calcium oxalate crystals.
Koide T; Yoshioka T; Yamaguchi S; Hosokawa S; Utsunomiya M; Sonoda T
Urol Res; 1990; 18(6):387-92. PubMed ID: 2100413
[TBL] [Abstract][Full Text] [Related]
13. Isolation and purification of a new glycoprotein from human urine inhibiting calcium oxalate crystallization.
Atmani F; Lacour B; Drüeke T; Daudon M
Urol Res; 1993 Jan; 21(1):61-6. PubMed ID: 8456540
[TBL] [Abstract][Full Text] [Related]
14. Purification and characterization of a calcium oxalate monohydrate crystal growth inhibitor from human kidney tissue culture medium.
Nakagawa Y; Margolis HC; Yokoyama S; Kézdy FJ; Kaiser ET; Coe FL
J Biol Chem; 1981 Apr; 256(8):3936-44. PubMed ID: 7217065
[No Abstract] [Full Text] [Related]
15. The influence of urinary macromolecules on calcium oxalate monohydrate crystal growth.
Lanzalaco AC; Singh RP; Smesko SA; Nancollas GH; Sufrin G; Binette M; Binette JP
J Urol; 1988 Jan; 139(1):190-5. PubMed ID: 3336094
[TBL] [Abstract][Full Text] [Related]
16. Intracrystalline proteins and urolithiasis: a synchrotron X-ray diffraction study of calcium oxalate monohydrate.
Fleming DE; Van Riessen A; Chauvet MC; Grover PK; Hunter B; van Bronswijk W; Ryall RL
J Bone Miner Res; 2003 Jul; 18(7):1282-91. PubMed ID: 12854839
[TBL] [Abstract][Full Text] [Related]
17. Nephrocalcin: biosynthesis by human renal carcinoma cells in vitro and in vivo.
Nakagawa Y; Sirivongs D; Novy MB; Netzer MF; Michaels E; Vogelzang NJ; Coe FL
Cancer Res; 1992 Mar; 52(6):1573-9. PubMed ID: 1540966
[TBL] [Abstract][Full Text] [Related]
18. An unidentified macromolecular inhibitory constituent of calcium oxalate crystal growth in human urine.
Sørensen S; Hansen K; Bak S; Justesen SJ
Urol Res; 1990; 18(6):373-9. PubMed ID: 2100411
[TBL] [Abstract][Full Text] [Related]
19. Protein inhibitors of crystal growth.
Kaiser ET; Bock SC
J Urol; 1989 Mar; 141(3 Pt 2):750-2. PubMed ID: 2645434
[TBL] [Abstract][Full Text] [Related]
20. Modulatory effect of the 23-kD calcium oxalate monohydrate binding protein on calcium oxalate stone formation during oxalate stress.
Asokan D; Kalaiselvi P; Varalakshmi P
Nephron Physiol; 2004; 97(1):p23-30. PubMed ID: 15153748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]